Escitalopram affects cytoskeleton and synaptic plasticity pathways in a rat gene–environment interaction model of depression as revealed by proteomics. Part II: environmental challenge
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Large-scale investigations aimed at elucidating the molecular mechanism of action of antidepressant treatment are achievable through the application of proteomic technologies. We performed a proteomic study on the Flinders Sensitive Line (FSL), a genetically selected rat model of depression, and the control Flinders Resistant Line (FRL). To evaluate gene-environment interactions, FSL and FRL animals were separated from their mothers for 3 h from postnatal days 2 to 14 (maternal separation; MS), since early-life trauma is considered an important antecedent of depression. All groups received either escitalopram (Esc) admixed to food pellets (25 mg/kg.d) or vehicle for 1 month. Protein extracts from prefrontal/frontal cortex and hippocampus were separated by 2D electrophoresis. Proteins differentially modulated were identified by mass spectrometry. Bioinformatics analyses were performed to discover gene ontology terms associated with the modulated proteins. This paper was focused on the modifications induced by the environmental challenge of MS, both on the predisposed genetic background and on the resistant phenotype. The combination between Esc treatment and MS was investigated by comparing the MS, Esc-treated rats with rats subjected to each single procedure. In MS rats, antidepressant treatment influenced mainly proteins involved in carbohydrate metabolism in FSL rats and in vesicle-mediated transport in FRL rats. When studying the interaction between Esc and MS vs. non-separated rats, proteins playing a role in cytoskeleton organization, neuronal development, vesicle-mediated transport and synaptic plasticity were identified. The results provide further support to the available reports that antidepressant treatment affects intracellular pathways and also suggest new potential targets for future therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hammen, C. (2005) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.1.102803.143938 · Cited by 2,979 · cited 5×
“The aim of this work was to analyse the effect of Esc administration on protein levels in a rat model of MDD, incorporating both the genetic and environmental components.”
MethodInfluentialNew approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · cited 2×
“All groups received either escitalopram (Esc) admixed to food pellets (25 mg/kg.d) or vehicle for 1 month.”
BackgroundMethodAnderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940 · cited 1×
“Two major mechanisms of action account for the efficacy of available antidepressants : blockade of neurotransmitter re-uptake and the inhibition of its degradation (Anderson, 2000; Arroll et al. 2005; Papakostas et al. 2007).”
BackgroundBessa, J. M., Ferreira, D., Melo, I., Marques, F., Cerqueira, J. J., Palha, J. A., Almeida, O. F. X., & Sousa, N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.119 · Cited by 598 · cited 1×
“In rats, exposure to unpredictable chronic mild stress reduced synapsin I mRNA expression in prefrontal cortex, while antidepressant treatment reversed this alteration (Bessa et al. 2009).”
BackgroundArroll, B. (2005) · The Annals of Family Medicine · doi:10.1370/afm.349 · Cited by 351 · cited 2×
“Two major mechanisms of action account for the efficacy of available antidepressants : blockade of neurotransmitter re-uptake and the inhibition of its degradation (Anderson, 2000; Arroll et al. 2005; Papakostas et al. 2007).”
BackgroundPapakostas, G. I., Thase, M. E., Fava, M., Nelson, J. C., & Shelton, R. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.027 · Cited by 308
Pennington, K., Beasley, C. L., Dicker, P., Fagan, A., English, J., Pariante, C. M., Wait, R., Dunn, M. J., & Cotter, D. R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002098 · Cited by 227 · cited 1×
“Several members of this protein family showed a dysregulation in the dorsolateral prefrontal cortex of bipolar disorder and schizophrenia patients (Pennington et al. 2008), indicating an important role for this class of proteins in the pathophysiology of psychiatric disorders.”
Background
Cited by
Kraus, C., Castrén, E., Kasper, S., & Lanzenberger, R. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.03.007 · Cited by 471
Neurochemical mechanisms underlying serotonergic modulation of neuroplasticity in humans
Melo, L., Beaupain, M. C., Ghanavati, E., Kuo, M.-F., & Nitsche, M. A. (2024) · Brain Stimulation · doi:10.1016/j.brs.2024.04.001 · Cited by 15
“The effects of 5-HT on plasticity are associated with different receptor subtypes [7,8], and it was shown in animal [9 – 11] and human studies [12 – 15] that LTP is enhanced after increasing 5-HT levels.”
BackgroundSenserrich, J., Castro, E., Florensa-Zanuy, E., Díaz, Á., Pazos, Á., Adell, A., Tzinia, A., & Pilar-Cuéllar, F. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00716-5 · Cited by 2
Metadata
- Authors
- Piubelli, C., Vighini, M., Mathé, A. A., Domenici, E., & Carboni, L.
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-07
- Volume
- 14
- Issue
- 6
- Pages
- 834-855
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2143315022
- Cited by
- 35
- References
- 7
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Escitalopram affects cytoskeleton and synaptic plasticity pathways in a rat gene–environment interaction model of depression as revealed by proteomics. Part II: environmental challenge. https://app.cochat.ai/papers/10.1017/s1461145710001306
- The paper
- Piubelli, C., Vighini, M., Mathé, A. A., Domenici, E., & Carboni, L. (2011). Escitalopram affects cytoskeleton and synaptic plasticity pathways in a rat gene–environment interaction model of depression as revealed by proteomics. Part II: environmental challenge. International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145710001306
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.